Company Search:
Advanced Search
Sponsored Links
Neurovive Pharmaceutical AB Company Snapshot
Neurovive Pharmaceutical AB operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Neurovive Pharmaceutical AB with three other miscellaneous service companies in Europe: Etaireia Investments Plc of the United Kingdom (2016 sales of £1,200.00 [US$1,655.17 ] ), Targovax ASA of Norway (37,000.00 Norwegian Kroner [US$4,694.93 ] ), and Xintela AB (3,000.00 Swedish Kronor [US$374.40 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Neurovive Pharmaceutical AB
  Stock Performance Chart for Neurovive Pharmaceutical AB
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 3.67
(Figures in Swedish Kronor)
1 Week -0.9%   13 Weeks 11.4%  
4 Weeks -17.6%   52 Weeks 2.9%  
Neurovive Pharmaceutical AB Key Data:
  Ticker: NVP Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 14,000
(Year Ending Jan 2017).
Employees: 23
  Currency: Swedish Kronor Market Cap: 181,265,934
  Fiscal Yr Ends: December Shares Outstanding: 49,458,645
  Share Type: Aktie Closely Held Shares: 16,052,660
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.